Rachel Flynn, PhD, Promoted to Associate Professor
Rachel Flynn, PhD, has been promoted to the rank of Associate Professor at Boston University School of Medicine. Dr. Flynn is a member of Pharmacology and Medicine, and a member of the BU-BMC Cancer Center, and her research focuses on DNA damage repair and mechanisms of telomere maintenance in cancer. Her work has led to the identification of genetic mutations that contribute to the activation of the alternative lengthening of telomeres (ALT) pathway and facilitated the development of small molecule inhibitors that target ALT positive cancers. Dr. Flynn is a a proponent of university-wide cancer initiatives, and has organized a seminar series showcasing BU research to unify interdisciplinary cancer researchers and foster collaborations within the university. Supported by funds to bring in outside speakers, the series has grown into a cancer community series uniting basic and clinical scientists. In April 2019, Dr. Flynn was appointed Co-Director of the Genome Science Institute to expand genetics and genomics research within the Cancer Center community. Read more